SB 253 requires Oklahoma's Medicaid agency (the Oklahoma Health Care Authority) to include specific funding details in its annual budget request. It mandates that the budget reflect new state and federal funding needed to cover the most recent audited costs for reimbursing nursing facilities and intermediate care facilities serving individuals with intellectual disabilities. The audited cost must be calculated using the latest cost report submitted to the agency. This change takes effect November 1, 2025.
HB 1658 regulates laser hair removal practitioners in Oklahoma by requiring all providers to use only FDA-approved devices and hold specific licenses or certifications. It mandates a 40-hour training program for practitioners (completed internally or via third parties under physician oversight), requires facilities to be overseen by a physician (with exemptions for Advanced Practice Registered Nurses), and establishes protocols for patient evaluations, informed consent, and complication management. The law also specifies that physicians must be available for real-time communication during procedures but need not be physically present. This bill directly affects laser hair removal practitioners, clinics, and supervising physicians, becoming effective immediately upon passage as an emergency measure.
HB 1516 allows minors aged 15-16 to contract for life, accident, or health insurance with parental or guardian consent, and minors aged 16+ to contract for other types of insurance with consent. It specifies that these minors are legally bound by their insurance contracts (including settlements) but cannot be held responsible for unpaid premiums on unperformed agreements. The law, effective November 1, 2025, amends Oklahoma's insurance code to clarify minor contracting rights and responsibilities. This directly affects minors seeking insurance coverage and their parents/guardians who must provide written consent.
SB 391 extends the Opioid Overdose Fatality Review Board's existence until July 1, 2026 (correcting the bill title's "dissolving" error), requiring it to review opioid overdose cases involving adults. The Board gathers confidential records from medical examiners, hospitals, law enforcement, and other agencies to identify systemic issues in medical or law enforcement responses, then makes recommendations for improvement. All case discussions and recommendations remain confidential and privileged, not admissible in court, while the Board must publish an annual public report by February 1 detailing its findings and system coordination. This directly affects state agencies (like mental health services, law enforcement, and medical examiners) and ensures public transparency through annual reports.
HB 2047, the Emerson Kate Cole Act, updates Oklahoma school medication policies to improve safety for students with allergies and asthma. It requires school districts to adopt policies allowing students to self-administer prescribed asthma inhalers, epinephrine for allergic reactions, and cystic fibrosis medications, with written parental permission and physician documentation. Key provisions include mandating annual staff training on recognizing allergic reactions and administering epinephrine, requiring schools to notify parents after medication use, and specifying protocols for stocking and using epinephrine injectors (including 911 contact procedures). The bill also creates model policies for districts to follow and clarifies that schools and staff incur no liability for medication administration under these guidelines. This law, effective May 14, 2025, directly affects public school districts, students with chronic conditions, and their families.
SB 806, the Food is Medicine Act, requires Medicaid contractors to expand nutrition services for enrollees, particularly those with diet-related health conditions like diabetes. It creates financial incentives for healthcare providers to offer medically tailored meals and nutrition counseling as part of Medicaid coverage. This directly affects Medicaid beneficiaries and their healthcare providers by integrating food-based health interventions into standard care. The law took immediate effect after Governor approval on May 8, 2025, without a waiting period.
SB 331, the Emerson Kate Cole Act, requires Oklahoma school employees to call 911 immediately after administering Epinephrine to a student experiencing an allergic reaction. It also mandates schools to notify parents or guardians when a student has a possible allergic reaction and to provide annual training for teachers and staff on recognizing anaphylaxis and using Epinephrine. The law amends existing school medication policies to clarify procedures for handling allergic emergencies and ensures staff are trained on emergency response. This directly affects students with severe allergies, school employees, and school districts across Oklahoma.
SB 56 requires the Oklahoma Health Care Authority to create a program that reimburses family caregivers for providing home care services. This directly affects family members who care for relatives with medical needs at home, such as elderly or disabled individuals. The bill establishes a specific reimbursement mechanism through the Authority, directing them to implement the program immediately as an emergency measure. It became law on May 12, 2025, without the Governor's signature.
SB 1019 requires Oklahoma health insurers to cover continuous anesthesia services without arbitrary time limits during medical procedures. It defines "anesthesia time" as the period from patient preparation through service discontinuation and mandates that insurers cannot restrict coverage or payment based on time duration. The law directly affects insurers and anesthesia providers by eliminating policies that previously limited coverage for procedures requiring extended anesthesia care. Effective November 1, 2025, this bill codifies these requirements into Oklahoma Statutes (Title 36, Section 7500).
HB 2049 requires Oklahoma's Medicaid managed care plans to comply with federal parity laws for mental health and substance use disorder coverage. It mandates regular compliance checks on nonquantitative treatment limitations (like prior authorization), creates a standardized process for handling parity complaints, and requires the Oklahoma Health Care Authority to publicly report on compliance. The law directly affects Medicaid managed care plans, the Oklahoma Health Care Authority, and Medicaid beneficiaries seeking mental health or substance use services. Key provisions include contract requirements for parity analysis, public disclosure of compliance reports, and a 30-day deadline for publishing federal reports. The bill became effective November 1, 2025.
